Nchi: Australia
Lugha: Kiingereza
Chanzo: APVMA (Australian Pesticides and Veterinary Medicines Authority)
LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE
ZOETIS AUSTRALIA PTY LTD
lincomycin as HCl(22g/kg)+spectinomycin as sulfate(22g/kg)
ORAL POWDER, PRE-MIX
LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 22.0 g/kg; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE ANTIBIOTIC Active 22.0 g/kg
20kg; 5kg
VM - Veterinary Medicine
ZOETIS AUSTRALIA
PIGS | BOAR | GILT | PIGLET | SOW | SWINE
NUTRITION & METABOLISM
BLOODY SCOURS | ENTERITIS ASSOCIATED WITH E.COLI | MYCOPLASMAL PNEUMONIA | PROMOTE ANIMAL GROWTH | SALMONELLOSIS | VIBRIONIC DYSENTERY | FEED CONVERSION | FINISHING | GROWTH PROMOTION | GROWTH RATE | LIVEWEIGHT GAIN | SWINE DYSENTERY
Poison schedule: 4; Withholding period: WHP: MEAT: Do not use less than 1 day before slaughter for human consumption. TRADE ADVICE: EXPORT SLAUGHTER INTERVA L (ESI): This product does not have and ESI established.; Host/pest details: PIGS: [BLOODY SCOURS, ENTERITIS ASSOCIATED WITH E.COLI, MYCOPLASMAL PNEUMONIA, SALMONELLOSIS, VIBRIONIC DYSENTERY]; For the treatment and control of swine dysentery; salmonellosis; enteritis associated with E. coli and as an aid in control of mycoplasmal pneumonia.DO NOT continue medication beyond the period prescribed by the veterinarian.
Registered
2023-07-01
LINCO-SPECTIN PREMIX ANTIBIOTIC FOR SWINE 38701/109777 Product Name: APVMA Approval No: Label Name: LINCO-SPECTIN PREMIX ANTIBIOTIC FOR SWINE Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 22 g/kg LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE 22 g/kg SPECTINOMYCIN AS SPECTINOMYCIN SULFATE Claims: For the treatment and control of swine dysentery (vibrionic dysentery, bloody scours); salmonellosis (necrotic enteritis); enteritis associated with E. Coli and as an aid in control of mycoplasmal pneumonia. Net Contents: 20kg 5kg Directions for Use: Restraints: Restraints DO NOT continue medication beyond the period prescribed by the veterinarian. Precautions: Precautions For use in pigs only. Do not allow rabbits, hamsters, guinea pigs, horses or ruminants access to feed containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Lincomycin should not be used in animals known to be hypersensitive to the product. Do not use the water treatment and the feed treatment simultaneously. Side Effects: Side effects Excessive dosage may lead to an increased incidence of side effects which may include rectal prolapse. Occasionally, swine treated with lincomycin, within the first two days after the onset of treatment, may develop diarrhoea and/or swelling of the anus. On rare occasions, some RLP APPROVED pigs may show reddening of the skin and irritable behaviour. These conditions have been self-correcting within 5 to 8 days without discontinuing lincomycin treatment. Dosage and Administration: For treatment and control of the diseases specified, complete feeds containing 44 grams of antibiotic activity per tonne should be fed. General Directions: Mixing Directions: LINCO-SPECTIN® Premix must be mixed thoroughly in feeds before use. For making Medicated Complete Feeds; Add 1 kg LINCO-SPECTIN® Premix per tonne of complete feed to give 44g of antibiotic activity per tonne. Medicated feed should constitute the sole ration of Soma hati kamili
PRODUCT NAME: LINCO-SPECTIN ® PREMIX ANTIBIOTIC FOR SWINE PAGE: 1 OF 5 THIS REVISION ISSUED: APRIL, 2010 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: (02)9850 3333 SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: (02) 9850 3333 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 SUBSTANCE: Active ingredients are antibiotics. TRADE NAME: LINCO-SPECTIN ® PREMIX ANTIBIOTIC FOR SWINE PFIZER MSDS CODE: MSDS 090 PRODUCT USE: Antibiotic. CREATION DATE: JANUARY, 2005 REVISION DATE: APRIL, 2010 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of NOHSC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Tan coloured powder. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S Repeated overexposure to lincomycin may cause abdominal cramps, diarrhoea and colitis. This may begin several weeks after exposure has ceased. Some hematopoietic effects have been reported with the use of lincomycin. Hypersensitivity reactions have been reported in people known to be sensitive to penicillin. Rare instances of erythema multiforme, some resembling Stevens-Johnsone Syndrome, have been associated with lincomycin hydrochloride. INHALATION SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. Long term inhalation Soma hati kamili